Page 2,039«..1020..2,0382,0392,0402,041..2,0502,060..»

Connecticut Catholics respond to ALS ice bucket controversy

Posted: August 23, 2014 at 9:57 am

HARTFORD, CT (WFSB/CBS) -

The viral sensation where people douse themselves with a bucket of ice water to raise awareness for ALS is not sitting well with some Connecticut members of the Catholic Church.

Officials with the church gave their own icy response to the "Ice Bucket Challenge." They want to know where the money is going.

From President George W. Bush to Kermit the Frog, every minute someone else is posting a video of the challenge.

Charles Mihaliak said he can't refresh his Facebook feed without seeing someone new try it. But for now, Mihaliak said he isholding back.

"That would be one of the big things that would hold me back from doing the ice bucket challenge,"Mihaliak, who is an altar server, said. "I would like to raise money for it, but if it goes against my beliefs as a Catholic."

The ALS Association said the phenomenon has done wonders for its fundraising. Money raised topped $41 million since July. That's compared to just about $2 million last year.

"I've had several Catholics tell me today that they were unaware of how research is done for that disease," said Steve Trosley, Archdiocese of Cincinnati, told our sister station WXIX.

Catholic leaders in a handful of Dioceses across country are asking ask if you donate, do it in a way that's consistent with the sanctity of life.

"Since the only way you can harvest embryonic stem cells is from an aborted fetus, we are morally opposed to that," Trosley said.

Read the rest here:

Connecticut Catholics respond to ALS ice bucket controversy

Posted in Connecticut Stem Cells | Comments Off on Connecticut Catholics respond to ALS ice bucket controversy

Stem Cell Transplant, Bone Marrow Transplant | Health …

Posted: August 23, 2014 at 9:57 am

What is a stem cell transplant?

A stem cell transplant may be used so that you can have intensive high-dose chemotherapy (and sometimes radiotherapy) to kill cancerous cells. The chemotherapy is higher than conventional chemotherapy and also kills the stem cells in the bone marrow that would normally make blood cells. Therefore, following the chemotherapy, you are given back (transplanted) stem cells which can then make normal blood cells again.

A stem cell transplant is sometimes called a bone marrow transplant. However, stem cells can be obtained from blood as well as from the bone marrow. So, the term stem cell transplant is now used.

Blood cells are made in the bone marrow, by stem cells. Bone marrow is the soft sponge-like material in the centre of bones. Large flat bones such as the breastbone (sternum) and pelvis contain the most bone marrow. To make blood cells constantly you need a healthy bone marrow. You also need nutrients from your diet, including iron and some vitamins.

Stem cells are primitive (immature) cells. There are two main types in the bone marrow - myeloid and lymphoid stem cells. These derive from even more primitive cells called common pluripotent stem cells. Stem cells constantly divide and produce new cells. Some new cells remain as stem cells and others go through a series of maturing stages (precursor or blast cells) before forming into mature blood cells.

Mature (fully formed) blood cells are released from the bone marrow into the bloodstream. Mature blood cells are:

Stem cells rapidly multiply to make millions of blood cells each day. Because of this they are more easily killed by chemotherapy than most other cells in the body. This is because chemotherapy drugs work by killing rapidly dividing cells (such as cancer cells).

A stem cell transplant is an option which is considered for various cancer conditions. For example, for types of leukaemia, lymphoma and myeloma. Your specialist will advise when it may be an appropriate option. As a rule, it is not often a first-line treatment. Conventional chemotherapy or other treatments tend to be used first. However, the treatment of cancer and leukaemia is a changing and developing area of medicine. Techniques such as stem cell transplant continue to be refined and improved and may be considered in various different circumstances.

The higher doses of chemotherapy and radiotherapy that can be used in conjunction with a stem cell transplant can improve the chance of a cure for some conditions in certain circumstances.

A stem cell transplant is also used for some rare noncancerous blood disorders.

Read more:

Stem Cell Transplant, Bone Marrow Transplant | Health ...

Posted in Colorado Stem Cells | Comments Off on Stem Cell Transplant, Bone Marrow Transplant | Health …

Glossary [Stem Cell Information]

Posted: August 23, 2014 at 9:57 am

Adult stem cellsee somatic stem cell.

Astrocytea type of supporting (glial) cell found in the nervous system.

BlastocoelThe fluid-filled cavity inside the blastocyst, an early, preimplantation stage of the developing embryo.

BlastocystA preimplantation embryo of about 150 cells produced by cell division following fertilization. The blastocyst is a sphere made up of an outer layer of cells (the trophoblast), a fluid-filled cavity (the blastocoel), and a cluster of cells on the interior (the inner cell mass).

Bone marrow stromal cellsA population of cells found in bone marrow that are different from blood cells, a subset of which are multipotent stem cells, able to give rise to bone, cartilage, marrow fat cells, and able to support formation of blood cells.

Cell-based therapiesTreatment in which stem cells are induced to differentiate into the specific cell type required to repair damaged or destroyed cells or tissues.

Cell cultureGrowth of cells in vitro in an artificial medium for research or medical treatment.

Cell divisionMethod by which a single cell divides to create two cells. There are two main types of cell division depending on what happens to the chromosomes: mitosis and meiosis.

Chromosomea structure consisting of DNA and regulatory proteins found in the nucleus of the cell. The DNA in the nucleus is usually divided up among several chromosomes.The number of chromosomes in the nucleus varies depending on the species of the organism. Humans have 46 chromosomes.

Clone (v) To generate identical copies of a region of a DNA molecule or to generate genetically identical copies of a cell, or organism; (n) The identical molecule, cell, or organism that results from the cloning process.

View post:

Glossary [Stem Cell Information]

Posted in Colorado Stem Cells | Comments Off on Glossary [Stem Cell Information]

California Stem Cell Report – blogspot.com

Posted: August 23, 2014 at 9:56 am

All that talk about the agency running out of money for new awards in 2017? Bushwa, he basically said. Its simply not true, he told the directors of the agency at their meeting in Millbrae.

Mills' comments appeared to be directed at media stories, including those on this Web site, that mention the 2017 timetable. However, the date was not concocted by the writers of those stories. It came directly from the agency itself, which has never challenged it until Mills did last week. The timetable was even referenced as recently as December 2013 by the agencys directors.

A case in point came last week when Mills recommended and the board approved slicing $5 million out of a $15 million component of the agencys Alpha clinic RFAs. It was the first time that the board has so heavily cut a previously approved "concept" figure.

Pat Olson, executive director of scientific activities, said,

Enter Mills five months later as president. By last week, he was telling board members that, yes, they have enough money to give out awards until 2020 at a rate of $190 million a year. He said that about $1 billion is available.

Of course, if the agency spends more than $190 million a year, the money will run out faster. And the agency is engaged in clinical trials and commercialization efforts, which are far more expensive than basic research.

But Mills 2020 timetable has some significant advantages even if it slows the pace of awards. It gives the agency substantially more time to arrange some sort of financing for the future. Currently its only real source of funding is state bonds. Its ability to authorize those bonds ends in 2017, according to the agency. Currently Thomas is examining the possibility of some sort of private-public financing arrangement. Asking voters to approve another bond measure has not been ruled out, but it could be problematic politically. The additional time would improve the possibility that clinical trial results would emerge that would resonate with the public as well as with private funding sources.

While Mills paints a rosier financial picture than the agency previously offered, he also has demonstrated a clear fondness for focused austerity. It fits with the mood of the board. Juelsgaard, who is chairman of the agencys Finance Subcommittee, is also attempting to bring a sharper financial perspective to the agency at a time when directors are clearly feeling a pinch.

Instead last December, after directors were told that only $629 million out of $3 billion was left uncommitted, CIRM DirectorJeff Sheehy, in a comment echoed in tone by other board members, said,

One of Mills first public actions involved the agencys $17 million annual operational budget, which is limited by state law. On top of those limitations, in May he whittled the spending plan down to the point where it could be described as less than the previous fiscal year, given inflation.

See the rest here:

California Stem Cell Report - blogspot.com

Posted in California Stem Cells | Comments Off on California Stem Cell Report – blogspot.com

UC San Diego Stem Cell Program

Posted: August 23, 2014 at 9:56 am

Yeo Lab Takes the ALS Ice Bucket Challenge

Principal Investigator Gene Yeo and his lab take the ALS Ice Bucket Challenge to raise awareness about Amyotrophic lateral sclerosis (ALS), a progressive neurodegenerative disease. For more information, visit the ALS Ice Bucket Challenge andYeo Labwebsites.

The Sanford Stem Cell Clinical Center at UC San Diego Health System exists to transform the enormous potential of stem cell science into real therapies for patients. More information is available on the UC San Diego Health Systems website.

The La Jolla Light features an article by Dr. Scott Lippman on the Sanford Consortium's unprecedented collaboration of five leading scienfic institutions to advance stem cell research; "critical to catalyze major advances in cancer research and care."

This 2010 CBS News feature explores the danger of bogus therapies using stem cells.

The Hertzberg Schechter awards committee unanimously approved Dr. Beatriz C.G. de Freitas for the prize, valued at $10,000, to support a research trip to the Weizmann Institute in Israel to engage in collaborative research and seed collaborative research for two to four weeks. Dr. Freitas is interested in modeling normal and affected early stages of human nervous system development using pluripotent stem cells, focusing on human astrocytes. (Image: [left to right] Richard Hertzberg; Sylvia M. Evans, Ph.D; Beatriz Freitas, Ph.D; Larry Goldstein, Ph.D)

The selection committee is seeking applicants who have an MD degree, are in a fellowship program at UC San Diego, have stem cell related research projects in mind, and have time available during their current fellowship to pursue them. Stipends are competitive, and recipients can perform up to 25% clinical service. Please email jbraswell "@" ucsd.edu for more info.

Larry Goldstein speaks at an event held by the California Healthcare Institute at the Salk Institute in July, 2013, covered by the San Diego Union-Tribune.

Original post:

UC San Diego Stem Cell Program

Posted in California Stem Cells | Comments Off on UC San Diego Stem Cell Program

California Stem Cell Report: Capricor and California Stem …

Posted: August 23, 2014 at 9:56 am

One recent headline in Forbes magazine read, Stem Cell Therapy To Fix The Heart: A House Of Cards About ToFall? A provocative new study calls into question the rationale for using stem cells to repair the heart a much-hyped experimental therapy that grew out of insights from a groundbreaking Boston researchers laboratory. But it appears that heart stem cell regeneration is like cheese, you might say. There are many different varieties. And in the case of a $27 million investment in heart cell regeneration by the California stem cell agency, all the players say things are just fine with their project.

The state's research effort involves a publicly traded company called Capricor Therapeutics. The Beverly Hills firm and one of its founders. Eduardo Marban, director of the Cedars-Sinai Heart Institute in Los Angeles, received the $27 million from the state stem cell agency.

In the wake of the news reports involving heart stem cell regeneration, the California Stem Cell Report queried both Marban and the stem cell agency. Marban replied within 37 minutes last week. Here is the text of what he had to say in his email.

Although some alarmist headlines have inappropriately questioned all cardiac stem cell work, the issues have to do with only one specific subtype of cardiac stem cell, which is marked by the expression of an antigen called c-kit. This is NOT the cell type being developed by Capricor; in fact, my laboratory has found that c-kit-positive cells play no role in Capricors cell product. That product, known as CAP-1002, contains a small fraction (less than 5 percent) of c-kit-positive cells which can be completely removed with no loss in potency. CAP-1002 is believed to work by indirect 'paracrine' mechanisms that differ fundamentally from those postulated for the c-kit-positive cells.

These concerns in no way undermine Capricors technology. In fact, CAP-1002 remains the only heart-derived cell product in commercial development. I am proceeding full speed ahead with mechanistic and translational work on CAP-1002, and Capricor continues to feel bullish about the product, which is now in phase 2 trials (the furthest along of any CIRM-funded project).

Kevin McCormack, a spokesman for the stem cell agency, also said that Capricor is using a different method and a different stem cell than the one being called into question.

(Editor's note: If you would like a copy of the Nature paper that Marban referenced, please send an email to djensen@californiastemcellreport.com.)

More:

California Stem Cell Report: Capricor and California Stem ...

Posted in California Stem Cells | Comments Off on California Stem Cell Report: Capricor and California Stem …

What are adult stem cells? [Stem Cell Information]

Posted: August 23, 2014 at 9:56 am

Introduction: What are stem cells, and why are they important? What are the unique properties of all stem cells? What are embryonic stem cells? What are adult stem cells? What are the similarities and differences between embryonic and adult stem cells? What are induced pluripotent stem cells? What are the potential uses of human stem cells and the obstacles that must be overcome before these potential uses will be realized? Where can I get more information?

An adult stem cell is thought to be an undifferentiated cell, found among differentiated cells in a tissue or organ. The adult stem cell can renew itself and can differentiate to yield some or all of the major specialized cell types of the tissue or organ. The primary roles of adult stem cells in a living organism are to maintain and repair the tissue in which they are found. Scientists also use the term somatic stem cell instead of adult stem cell, where somatic refers to cells of the body (not the germ cells, sperm or eggs). Unlike embryonic stem cells, which are defined by their origin (cells from the preimplantation-stage embryo), the origin of adult stem cells in some mature tissues is still under investigation.

Research on adult stem cells has generated a great deal of excitement. Scientists have found adult stem cells in many more tissues than they once thought possible. This finding has led researchers and clinicians to ask whether adult stem cells could be used for transplants. In fact, adult hematopoietic, or blood-forming, stem cells from bone marrow have been used in transplants for more than 40 years. Scientists now have evidence that stem cells exist in the brain and the heart, two locations where adult stem cells were not at firstexpected to reside. If the differentiation of adult stem cells can be controlled in the laboratory, these cells may become the basis of transplantation-based therapies.

The history of research on adult stem cells began in the 1950s, when researchers discovered that the bone marrow contains at least two kinds of stem cells. One population, called hematopoietic stem cells, forms all the types of blood cells in the body. A second population, called bone marrow stromal stem cells (also called mesenchymal stem cells, or skeletal stem cells by some), were discovered a few years later. These non-hematopoietic stem cells make up a small proportion of the stromal cell population in the bone marrow, and can generate bone, cartilage, fat, cells that support the formation of blood, and fibrous connective tissue.

In the 1960s, scientists who were studying rats discovered two regions of the brain that contained dividing cells that ultimately become nerve cells. Despite these reports, most scientists believed that the adult brain could not generate new nerve cells. It was not until the 1990s that scientists agreed that the adult brain does contain stem cells that are able to generate the brain's three major cell typesastrocytes and oligodendrocytes, which are non-neuronal cells, and neurons, or nerve cells.

Adult stem cells have been identified in many organs and tissues, including brain, bone marrow, peripheral blood, blood vessels, skeletal muscle, skin, teeth, heart, gut, liver, ovarian epithelium, and testis. They are thought to reside in a specific area of each tissue (called a "stem cell niche"). In many tissues, current evidence suggests that some types of stem cells are pericytes, cells that compose the outermost layer of small blood vessels. Stem cells may remain quiescent (non-dividing) for long periods of time until they are activated by a normal need for more cells to maintain tissues, or by disease or tissue injury.

Typically, there is a very small number of stem cells in each tissue, and once removed from the body, their capacity to divide is limited, making generation of large quantities of stem cells difficult. Scientists in many laboratories are trying to find better ways to grow large quantities of adult stem cells in cell culture and to manipulate them to generate specific cell types so they can be used to treat injury or disease. Some examples of potential treatments include regenerating bone using cells derived from bone marrow stroma, developing insulin-producing cells for type1 diabetes, and repairing damaged heart muscle following a heart attack with cardiac muscle cells.

Scientists often use one or more of the following methods to identify adult stem cells: (1) label the cells in a living tissue with molecular markers and then determine the specialized cell types they generate; (2) remove the cells from a living animal, label them in cell culture, and transplant them back into another animal to determine whether the cells replace (or "repopulate") their tissue of origin.

Importantly, scientists must demonstrate that a single adult stem cell can generate a line of genetically identical cells that then gives rise to all the appropriate differentiated cell types of the tissue. To confirm experimentally that a putative adult stem cell is indeed a stem cell, scientists tend to show either that the cell can give rise to these genetically identical cells in culture, and/or that a purified population of these candidate stem cells can repopulate or reform the tissue after transplant into an animal.

Read the original post:

What are adult stem cells? [Stem Cell Information]

Posted in Arkansas Stem Cells | Comments Off on What are adult stem cells? [Stem Cell Information]

The Case for Adult Stem Cell Research – 21st Century Home Page

Posted: August 23, 2014 at 9:56 am

For more articles on biology and medicine, see Biology and Medicine categories in index.

BIOLOGY & MEDICINE

The Case for Adult Stem Cell Research

by Wolfgang Lillge, M.D.

(Full text of article from Winter 2001-2002 21st Century)

Problems of Therapeutic Cloning

Whoever Would Cure, Must Use Adult Stem Cells

Human Treatments

For more articles on biology and medicine, check the subject index

The question of stem cells is currently the dominant subject in the debate over biotechnology and human genetics: Should we use embryonic stem cells or adult stem cells for future medical therapies? Embryonic stem cells are taken from a developing embryo at the blastocyst stage, destroying the embryo, a developing human life. Adult stem cells, on the other hand, are found in all tissues of the growing human being and, according to latest reports, also have the potential to transform themselves into practically all other cell types, or revert to being stem cells with greater reproductive capacity. Embryonic stem cells have not yet been used for even one therapy, while adult stem cells have already been successfully used in numerous patients, including for cardiac infarction (death of some of the heart tissue).

View post:

The Case for Adult Stem Cell Research - 21st Century Home Page

Posted in Arkansas Stem Cells | Comments Off on The Case for Adult Stem Cell Research – 21st Century Home Page

Stem Cell Therapy | Arizona Pain Stem Cell Institute …

Posted: August 23, 2014 at 9:56 am

What is a Stem Cell? The various tissues of the body are made up of different types of cells (such as nerve cells, fat cells, muscle cells, etc.). As cells need to be replaced, these individual cells divide to create new cells of the same type: muscle cells create new muscle cells, skin cells create new skin cells, and so on. However, if you trace the lineage of those specific types of cells back far enough, you would find that they came from cells that were not specific to one type of body tissue they had the potential to become many or even all of the other types of cells. Those versatile cells are called stem cells.

Stem cells are often associated with embryos and fetal development, as stem cells are abundant during this period. Research on the use of embryonic stem cells has been controversial. However, there are other sources of stem cells. For example, stem cells are present after birth. Even adults have stem cells in their bodies, though the concentration declines with age. These cells are known as adult stem cells. In other cases, researchers have been able to modify mature cells so that they can specialize into other types of cells. These cells are known as induced stem cells.

Though researchers previously believed that such cells existed, the multipotency of stem cells was demonstrated in 1963.1 By the late 1960s, researchers were using the bone marrow, which contains a high concentration of stem cells, as a source of stem cells to treat conditions such as leukemia and sickle cell anemia.

Once stem cells reach the treatment site, they specialize into the cells composing specific tissues, for example cartilage or tendons. This enables the tissues of an organ or body part that have been damaged or degenerated to repair. Once the stem cells specialize, the new cells can continue to divide leading to regeneration and potentially reduced pain and improved functioning over the course of months.

The stem cell treatment used in this study uses autologous stem cells, meaning they come from the patient themselves. These stem cells come from bone marrow extracted from the patients hip bone. The stem cells in the bone marrow are then concentrated and injected into the degenerated joint. This bone marrow extraction and injection is done in a single outpatient procedure.

Because the stem cells used in these studies are derived from the patients own bone marrow, risks related to donor compatibility and rejection of cells are avoided. However, like any type of procedure, there are risks associated with the extraction of bone marrow and the injection of stem cells, including irritation or pain at the sites of extraction and injection or possibly infection. Discuss these with your health care provider prior to getting this procedure.

Because many patients painful conditions are adequately addressed by conservative treatments, we recommend that patients pursue this treatment only if they continue to experience moderate to extreme pain after trying conservative treatments such as rest, physical therapy, and non-steroidal anti-inflammatory drugs (e.g., ibuprofen).

Though research on stem cell therapy continues, there are promising results of to date of its efficacy for regenerating tissues and relieving symptoms for a number of conditions including joint repair.2 Based on the available research, we believe stem cells will be effective in relieving pain for many patients. Regeneration from stem cells takes place gradually. After receiving stem cell therapy, it may a few months for patients to notice the results. Further, as with any treatment for pain, not every patient will have success with this treatment.

1. Becker AJ, McCulloch EA, Till JE. Cytological demonstration of the clonal nature of spleen colonies derived from transplanted mouse marrow cells. Nature 1963;197:452-4.

2. Kamei G, Kobayashi T, Ohkawa S, Kongcharoensombat W, Adachi N, Takazawa K, Shibuya H, Deie M, Hattori K, Goldberg JL, Ochi M. Articular cartilage repair with magnetic mesenchymal stem cells. Am J Sports Med 2013 Apr 19. [epub ahead of print]

See original here:

Stem Cell Therapy | Arizona Pain Stem Cell Institute ...

Posted in Arizona Stem Cells | Comments Off on Stem Cell Therapy | Arizona Pain Stem Cell Institute …

Stem Cell Therapy Arizona | Scottsdale, Tempe, Glendale …

Posted: August 23, 2014 at 9:56 am

A New Frontier: Stem Cell Therapy for Low Back Pain.

Back pain is a very common complaint. It is the second most common complaint made to a primary care doctor by a patient, surpassed only by the common cold. It is estimated that 331 million Americans have low back pain at any given time and one of every two adults in the U.S. experience at least one day of back pain every year.

There are many reasons why people have back pain, but one of the most common causes is degeneration of discs in the spine. As we age, there is a normal amount of expected wear and tear of our spinal discs; however, arthritis in our spine can accelerate this process and can in turn lead to low back pain, stiffness, weakness, and eventually, loss of function.

Current treatment for low back pain includes exercise and physical therapy, medications such as anti-inflammatories, therapeutic injections, and ultimately surgery. These treatments are aimed at maximizing function, and returning the patient to as normal a life as possible.

As science progresses, we are gaining further understanding of how the degeneration process occurs in the spine. At a cellular level, there is continual loss of healthy cells inside the disc that is responsible for the degeneration of the discs structure. Eventually, normal cells are replaced with fibrotic cells, and the walls of the discs break down. This could lead to bulging discs, protrusions, and bone spurs from neighboring vertebrae begin to form. This process leads down its own pathway of natural degeneration, but what if there was a way to reverse this and return normal, healthy cells to our discs?

Every person carries inside their bodies cells that have the ability to form new and healthy tissues. In fact, adult stem cells are found throughout the body and exist in order to replenish dying cells and regenerate healthy tissue. Muscles, bones, cartilage and tendons all come from a certain kind of adult stem cell called Mesenchymal stem cells. The main reservoirs of Mesenchymal stem cells are bone marrow and adipose (fat) tissue.

Scientists have known about these stem cells as early as 1993 and were deemed safe for therapeutic use in humans shortly thereafter. Since then, research has continued to show that they can aid in the repair of tendon ruptures, bone fractures, diseased muscles, and degenerated cartilage. Even more recent research has shown that adult Mesenchymal stem cells have the ability to produce new cells in lumbar discs, which are able to bring new healthy tissue to a degenerating disc.

If the procedure is performed by a specialist in the field, adult stem cells can be transferred into a persons degenerated disc safely and effectively in an outpatient setting, without resorting to surgery. Completed in the safe and sterile environment of an outpatient center, a small volume of stem cells can be easily harvested from a persons bone marrow. It is then spun down in a centrifuge to concentrate the stem cells. These cells are then injected into a lumbar disc utilizing x-ray technology to guide the injection.

The physicians at Southwest Spine & Sports are all well-qualified, fellowship trained experts on disc disorders, and have the experience to complete this stem cell transfer into degenerated discs. In fact, our team is at the beginning stage of initiating a research study for stem cell treatments into lumbar discs, the first of its kind ever in Arizona and one of only a handful in the entire United States.

Here is the original post:

Stem Cell Therapy Arizona | Scottsdale, Tempe, Glendale ...

Posted in Arizona Stem Cells | Comments Off on Stem Cell Therapy Arizona | Scottsdale, Tempe, Glendale …

Page 2,039«..1020..2,0382,0392,0402,041..2,0502,060..»